Abstract
Artificial intelligence (AI) has emerged as a transformative force in regenerative medicine, revolutionizing research, clinical applications, and personalized therapies. This article explores how AI accelerates the identification of biomarkers, optimizes cell and tissue engineering processes, and enhances treatment efficacy through personalized medicine approaches. AI's role in predictive analytics, robotic systems for tissue fabrication, and real-time monitoring tools underscores its potential to reshape the future of healthcare. Addressing ethical considerations is essential as AI continues to pave the way for innovative regenerative therapies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
